Why MD beats the market
Up 239% over three years while the S&P 500 rose 80%.
“This increase reflects growth in same-unit revenue of 2.8 percent, and to a lesser extent, growth in non-same unit activity, driven by recent acquisitions”
MD's Quality Score fell 3 points on Tue, Nov 10, to 15.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Up 239% over three years while the S&P 500 rose 80%.
“This increase reflects growth in same-unit revenue of 2.8 percent, and to a lesser extent, growth in non-same unit activity, driven by recent acquisitions”
| The company | Profit up 149% |
| Latest filing | 8-K, Oct 29 |
After its last 4 reports it closed -6.0% on average, higher 1 of 4 times.
Excellentfor quality, not price, 7 of 14 chart checks firingWhat the Quality Score means
MD is #63 of 552 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 63 |
Expected to report Thu Feb 18, before the open (in 100 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Sales of $501.4M, 2% more than a year ago.
“This increase of $8.5 million, or 1.7%, reflects growth in non-same unit activity of 1.1 percent, driven by recent acquisitions, partially offset by practice dispositions, and growth in same-unit revenue of 0.6 percent.”
| Line | Q3 2026 | Q2 2026 | Q3 2025 |
|---|---|---|---|
| Health care patient service | $434M | $419M | $422M |
Each quarter's sales and their share of its total. Figures as filed (SEC filing, Oct 29)
| Measure | Figure |
|---|---|
| Adjusted EBITDA | $290M to $300M |
“The decrease in Adjusted EBITDA was primarily due to higher expenses as compared to revenue growth at our existing units, partially offset by net favorable impacts from recent acquisitions.”
From its results filing (SEC filing · Oct 29)
Sales grew 2% a year over 5 years, fiscal 2020 to 2025.
Its share count grew 0.4% a year over 5 years.
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Oct 29, 2026 | +5.7% | +0.9% | +13.5% |
| Aug 4, 2026 | -10.3% | -5.9% | -0.7% |
| May 5, 2026 | -6.3% | -7.0% | +4.3% |
Sales grew in five of the last seven years, to $1.9B in 2025. It turned a profit in 2025 after a loss in 2024.
RSI 63.0, MACD above signal, above both averages. Not scored.
One trade disclosed in the last six months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: MD is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
“Competition in our business is generally based upon a number of factors, including reputation, experience and level of care and our affiliated physicians’ ability to provide cost-effective, quality clinical care.”
MD scores 15 today, which Breakaway calls Excellent. It is #63 of 552 in Healthcare by Quality Score, with 7 of 14 chart checks firing. Up 239% over three years while the S&P 500 rose 80%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
MD scores 15 today, which Breakaway calls Excellent (15 to 19). That is #63 of 552 in Healthcare by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind MD's 15.
Expected to report Thu Feb 18, before the open, a date Breakaway expects from the company's usual timing; the company has not confirmed it. MD closed higher after 1 of its last 4 reports. Past behavior, not a forecast.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free for 24 hours. No account. No card. Then keep going with a free account.